Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-03-20
2011-10-11
Solola, Taofiq A (Department: 1622)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
Reexamination Certificate
active
08034833
ABSTRACT:
The present invention relates to oral compositions which are useful for binding phosphorus in ingesta, and inhibiting absorption of phosphorus from the gastrointestinal tract of subjects. A method for binding phosphorus in ingesta and inhibiting its absorption from the gastrointestinal tract is also provided. The dietary supplements and pharmaceutical products and methods of the present invention are particularly useful in the treatment of hyperphosphatemia of chronic uremia and reducing serum phosphorus levels in patients requiring such therapy.
REFERENCES:
patent: 5496545 (1996-03-01), Holmes-Farley et al.
patent: 2006/0276538 (2006-12-01), Ashmead et al.
Biolink Life Sciences, Inc.
Casimir Jones SC
Solola Taofiq A
LandOfFree
Phosphorus binder for treatment of renal disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Phosphorus binder for treatment of renal disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phosphorus binder for treatment of renal disease will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4291297